SCHOLAR ROCK HOLDING CORPORATION Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SCHOLAR ROCK HOLDING CORPORATION stock issued during period, value, other for the quarter ending 2025-03-31 was $2.00K.
- SCHOLAR ROCK HOLDING CORPORATION stock issued during period, value, other for the quarter ending 2023-06-30 was $1.00K.
- SCHOLAR ROCK HOLDING CORPORATION stock issued during period, value, other for the quarter ending 2023-03-31 was $2.00K.
- SCHOLAR ROCK HOLDING CORPORATION stock issued during period, value, other for the quarter ending 2022-09-30 was -$10.00K.
- SCHOLAR ROCK HOLDING CORPORATION stock issued during period, value, other for fiscal 2023 was $3.00K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2025-03-31 | $2.00K 10-Q · filed 2026-08-06 | |
| 2023-12-31 | $3.00K 10-K · filed 2025-02-27 | |
| 2023-06-30 | $1.00K 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $2.00K 10-Q · filed 2024-11-12 | |
| 2022-09-30 | -$10.00K 10-Q · filed 2023-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |